GeminIQ Website Logo

Viewing ESMC free

Start free trial

Subscribe for full history, 90+ metrics, screener, watchlist...

ESCALON MEDICAL CORP

ESMC

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash
----110-101-
Cash And Cash Equivalents At Carrying Value
301111001011
Restricted Cash Current
000000000000
Accounts Receivable Gross
121222221222
Allowance For Doubtful Accounts Receivable
-0-0-0-0-0-0-0-0-0-0-0-0
Accounts Receivable Net
----222-122-
Accounts Receivable Net Current
1212---2---2
Inventory Net
222222222122
Other Assets Current
000000000000
Assets Current
744554444445
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
110000000001
Finite Lived Intangible Assets Net
000000000000
Deposits Assets Noncurrent
000000000000
Assets
855554555555
Liabilities And Stockhold…
Liabilities Current
Other Notes Payable Current
----000-000-
Notes Payable To Bank Current
0000---0---0
Short Term Borrowings
-----------0
Secured Debt Current
000000000000
Accounts Payable Current
111111111111
Accrued Liabilities Current
111111111111
Interest Payable Current
000000000000
Operating Lease Liability Current
000000000000
Deferred Revenue
----000-000-
Other Liabilities Current
----000-000-
Deferred Revenue Current
0000---0---0
Related Party Deposit Liabilities
-0----------
Liabilities Of Disposal Group Including Discontinu…
0000---0---0
Liabilities Current
333332333333
Other Long Term Notes Payable
000000000000
Operating Lease Liability Noncurrent
100000000000
Liabilities Noncurrent
----00000001
Liabilities
333332333333
Stockholders Equity
Preferred Stock Value
111111111111
Common Stock Value
000000000000
Additional Paid In Capital
707070707070707070707070
Retained Earnings Accumulated Deficit
-66-69-69-68-68-68-69-69-69-69-68-68
Stockholders Equity
422222222222
Liabilities And Stockholders Equity
855554555555
Preferred Stock Par Or Stated Value Per Share
0.0010.001-0.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
22-222222222
Preferred Stock Shares Issued
22-222222222
Common Stock Par Or Stated Value Per Share
0.0010.001-0.0010.0010.0010.0010.001--0.0010.001
Common Stock Shares Authorized
3535-353535353535353535
Common Stock Shares Issued
77-777777777
Preferred Stock Shares Outstanding
----200-----
Shares Outstanding
77-777777777

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-5.88%0.00%0.00%47.06%-5.88%0.00%-24.00%-24.00%----
20250.00%-25.00%0.00%31.25%0.00%18.75%55.56%18.52%40.74%-46.67%-46.67%-43.33%
202466.67%44.44%16.67%47.06%23.53%17.65%-5.26%-26.32%-42.11%0.00%0.00%-13.33%
2023----------48.57%-25.71%-25.71%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.59
1.65
1.67
1.72
1.92
1.95
1.66
1.65
1.58
1.64
1.66
1.63
Quick Ratio
1.94
1.06
0.98
0.92
1.23
1.17
0.99
1.04
0.89
1.09
1.08
1.07
Working Capital
4.03M
1.69M
1.69M
1.93M
2.32M
2.09M
1.77M
1.73M
1.52M
1.63M
1.72M
1.78M
Leverage & Debt
Debt to Equity
0.82
1.81
1.73
1.61
1.27
1.22
1.66
1.63
1.75
1.56
1.58
1.74
Interest Coverage TTM
-55.03
-11.33
-1.96
5.87
3.01
0.72
-2.71
-1.91
8.32
16.75
15.34
9.19
Debt Ratio
0.45
0.64
0.63
0.62
0.56
0.55
0.62
0.62
0.64
0.61
0.61
0.64
Efficiency & Turnover
Asset Turnover TTM
1.80
2.60
2.57
2.47
1.93
1.89
1.73
1.66
1.72
1.95
1.84
1.67
Days Sales Outstanding TTM
42.78
66.34
40.87
54.95
-
-
-
82.42
-
-
-
66.79
Receivables Turnover TTM
8.53
5.50
8.93
6.64
-
-
-
4.43
-
-
-
5.46
Per Share Metrics
Diluted EPS TTM
0.12
-0.02
-0.02
0.00
0.01
-0.00
-0.03
-0.02
0.04
0.09
0.08
0.02
Free Cash Flow Per Share TTM
-0.02
-0.05
0.06
0.05
0.00
0.02
-0.07
-0.09
0.01
0.01
0.07
0.04
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
41.48%
43.87%
45.38%
45.75%
-
-
-
-
-
-
-
-
Operating Profit Margin TTM
-7.82%
-1.62%
-0.36%
1.11%
1.66%
0.44%
-1.76%
-1.25%
5.35%
9.67%
8.91%
5.48%
Net Profit Margin TTM
15.61%
-2.56%
-1.40%
0.23%
0.78%
-0.40%
-2.45%
-1.50%
3.28%
7.52%
6.49%
2.54%
Growth Metrics
Net Revenue Growth (1Y)
20.78%
41.55%
43.06%
44.01%
13.29%
-4.46%
-8.17%
-4.20%
-4.20%
20.47%
22.77%
14.35%
Net Income Growth (1Y)
2,302.85%
801.02%
-18.61%
-122.43%
-72.93%
-105.10%
-134.72%
-156.54%
12.65%
-207.45%
-186.12%
-760.91%
EPS Growth (1Y)
2,302.85%
801.02%
-18.61%
-122.43%
-72.93%
-105.10%
-134.72%
-156.54%
12.65%
-207.45%
-186.12%
-760.91%
Valuation Metrics
P/E TTM
0.75
-4.00
-7.57
84.46
15.95
-27.58
-5.44
-8.29
6.75
2.82
4.03
8.37
P/B TTM
0.32
0.71
0.75
1.24
0.52
0.48
0.63
0.57
1.11
1.05
1.24
0.96
P/S TTM
0.12
0.10
0.11
0.20
0.13
0.11
0.13
0.12
0.22
0.21
0.26
0.21
Market Cap
1.33M
1.26M
1.26M
2.37M
1.19M
963.99K
1.11M
1.04M
1.85M
1.93M
2.37M
1.85M
Enterprise Value
-2.00M
926.61K
391.46K
1.83M
392.32K
190.15K
629.38K
832.29K
1.29M
1.54M
1.37M
967.26K
Calculated Values
Free Cash Flow TTM
-143.97K
-394.25K
424.10K
376.85K
15.85K
151.09K
-493.93K
-661.55K
42.49K
110.68K
494.55K
311.30K
Net Debt
-3.34M
-334.00K
-869.14K
-542.47K
-794.13K
-773.84K
-482.92K
-205.86K
-561.54K
-387.53K
-998.04K
-886.57K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Start free trial
No insider data available.

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart
2020-03-31
0.02%
Inst. Shares: 1,285
Shares Outstanding: 7,415,329
2019-12-31
0.02%
Inst. Shares: 1,314
Shares Outstanding: 7,415,329
2019-06-30
0.10%
Inst. Shares: 7,552
Shares Outstanding: 7,415,329
2019-03-31
0.10%
Inst. Shares: 7,552
Shares Outstanding: 7,415,329
2018-12-31
0.10%
Inst. Shares: 7,552
Shares Outstanding: 7,415,329

ESCALON MEDICAL CORP (ESMC) — SEC Financial Statements & Analysis

ESCALON MEDICAL CORP (ESMC) is a electromedical & electrotherapeutic apparatus company, incorporated in PA. ESCALON MEDICAL CORP trades on OTC as: ESMC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ESCALON MEDICAL CORP reported a 20.78% year-over-year revenue growth, a Gross Profit Margin of 41.48% (TTM), a Debt-to-Equity ratio of 0.82x, a Price-to-Sales (P/S) ratio of 0.12x (TTM), a Price-to-Book (P/B) ratio of 0.32x (TTM), at a market cap of $1.33M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
20.78%
Gross Profit Margin TTM
41.48%
Debt To Equity
0.82x
P/S TTM
0.12x
P/B TTM
0.32x
Market Cap
$1.33M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is ESCALON MEDICAL CORP in?

ESCALON MEDICAL CORP (ESMC) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is ESMC's market cap?

ESCALON MEDICAL CORP (ESMC) has a market capitalization of $1.33M as of 2026-03-31.

What is ESMC's P/E ratio?

ESCALON MEDICAL CORP (ESMC)'s trailing twelve month P/E ratio is 0.75x as of 2026-03-31.

What exchange does ESMC trade on?

ESCALON MEDICAL CORP (ESMC) trades on the OTC.

Where is ESCALON MEDICAL CORP incorporated?

ESCALON MEDICAL CORP is incorporated in PA.

Companies in Electromedical & Electrotherapeutic Apparatus

MDTMedtronic plcMASIMASIMO CORPLIVNLivaNova PLCITGRInteger Holdings CorpAXGNAxogen, Inc.TMDXTransMedics Group, Inc.

Wall Street's data.
Main Street's price.

Start 7-day free trial